Hepatic metastases from colorectal carcinoma;Metástasis hepáticas de carcinoma colorrectal

Cirugia Espanola

Volumn 73, Issue 1, 2003, Pages 68-73

  Torras, Jaume ^a   Figueres, Joan ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Colorrectal carcinoma; Hepatic metastases

Indexed keywords

EID: 84897585163     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(03)72094-6     Document Type: Article

References (40)

1. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer Clin 1999, 49:8-31.
2. Bengmark S., Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. The prognosis for patients with hepatic metastases from colonic and rectal carcinomas by laparotomy. Cancer 1969, 23:198-202.
3. Wagner J.S., Adson M.A., Van Heerden J.A. The natural history of hepatic matastases from colorectal cancer. A comparison with respective treatment. Ann Surg 1984, 199:502-508.
4. Culy C.R., Clemett D., Wissema L.R. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignances. Drugs 2000, 60:895-924.
5. Levi F., Zidani R., Misset J.L. Randomised multicentre trial of chronotherapy with oxaliplatin, fluoracil, and folinic acid in metastatic colorectal cancer. International organization for cancer chronotherapy. Lancet 1997, 350:681-686.
6. Nakamura S., Suzuki, Baba S. Resection of liver metastases of colorectal carcinoma. World J Surg 1997, 21:741-747.
7. Nordlinger B., Guiget M., Vaillant J.C., Balladur P., Boudjema K., Bachellier P.H., et al. Surgical resection of colrectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection. Cancer 1996, 771:1254-1262.
8. Scheele J., Stang R., Altendorf-Hofman A., Paul M. Resection of colorectal liver metastases. World J Surg 1995, 19:59-71.
9. Figueras J., Torras J., Valls C., Ramos E., Lama C., Busquets J., et al. Resección de metástasis hepáticas de carcinoma colorrectal. índice de resecabilidad y supervivencia a largo plazo. Cir Esp 2001, 70:27-33.
10. Couinaud C. Leading principles for controlled hepatectomies. Chirurgie 1980, 106:136-142.
11. Fong Y., Fortner J., Sun R.L., Brenan M.F., Blumgart L. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999, 230:309-321.
12. Kemeny N., Huang Y., Cohen A., Shi W., Conti J., Brennan M.F., et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999, 341:2039-2048.
13. Figueras J., Valls C., Rafecas A., Fabregat J., Ramos E., Jaurrieta E. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg 2001, 88:980-985.
14. Fortner J., Blumgart L. A historic perspective of liver surgery for tumors at the end of the millenium. J Am Coll Surg 2001, 193:210-222.
15. Choti M., Sitzman J., Tiburi M., Sumetchotimetha W., Rangsin R., Shulick R.D., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002, 235:759-766.
16. Bismuth H., Adam R., Levi F., Farabos C., Waechter F., Castaign D., et al. Resection of non resectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996, 224:509-522.
17. Azoulay D., Castaign D., Smail A., Adam R., Cailliez V., Laurent A., et al. Resection of nonresectable liver metastases from colorectal cancer after percuteneous portal vein embolization. Ann Surg 2000, 231:480-486.
18. López Ben S., Figueras J., Lama C., Busquets J., Domínguez J., Sancho C., et al. Resultados clínicos de la utilización de la oclusión portal preoperatoria en el tratamiento quirúrgico de las metástasis hepáticas. Cir Esp 2001, 70:152-156.
19. Jaeck D., Bachellier P., Giguet M., Boudjema K., Vaillant J.C., Balladur P., et al. Long-term survival following resection of colorectal hepatic metastases. Br J Surg 1997, 84:977-980.
20. Iwatsuky S., Dvorchik I., Madariaga J.R., Marsh W., Dodson F., Bonham A.C., et al. Hepatic resection for metastatic colorectal adenocarcinoma. A proposal of a prognostic scoring system. J Am Coll Surg 1999, 189:291-299.
21. Huebner R.H., Park K.C., Shepard J.E. A meta-analysis of the literature for whole body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000, 41:1177-1189.
22. Valls C., López E., Guma A., Figueras J., Torras J., Serrano T., et al. Hepatic metastases from colorectal cancer: preoperative detection and assesment of resecability with helical CT. Radiology 2001, 218:55-60.
23. Keogan M.T., Edelman R.R. Technological advances in MR imaging. Radiology 2001, 220:310-320.
24. Nagakura S.H., Shirai Y., Yamoto Y., Yokoyama N., Suda T., Hatakeyama K. Simultaneous detection of colorectal carcinoma liver and lung metastases does not warrant resection. J Am Coll Surg 2001, 193:153-160.
25. Brennan M.F. PET scaning in malignancy: infant, adolescent or mature citizen?. [editorial] Ann Surg 2001, 233:320-321.
26. Jarnagin W.R., Bach A.M., Winston C.B., Hann L.E., Heffernan N., Loumeau T., et al. What is the yield if intraoperative ultrasonography during partial hepatectomy for malignant disease. J Am Col Surg 2001, 195:577-583.
27. Fan S.T., Lai E.C., Lo C.M., Chu K.M., Liu C.L., Wong J. Hepatectomy with an ultrasonic dissector for hepatocellular carcinoma. Br J Surg 1996, 83:117-120.
28. Malassagne B., Cherqui D., Alon R., Bruneti F., Humeres R., Fagniez P.L. Safety of selective vascular clamping for major hepatectomies. J Am Coll 1998, 187:482-486.
29. Launois B., Jamieson G. The posterior intrahepatic approach for hepatectomy or removal of segments of the liver. Surg Gynecol Obstet 1992, 174:155-158.
30. Peppercon P.D., Reznec R.H., Wilson P., Slevin M.L., Gupta R.K. Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer 1998, 77:2008-2011.
31. Behrns K.E., Tsiotos G.G., DeSouza N.F., Krishna M.K., Ludwig J. Hepatic steatosis as a potential risk factor for major hepatic resecction. J Gastrointest Surg 1998, 2:292-298.
32. De Baere T., Elias D., Dromain C., Din M.G., Kuoch V., Ducreux M., et al. Radiofrequency ablation of 100 hepatic metastases with a mean folow-up of more than 1 year. Am J Roentgenol 2000, 175:1619-1625.
33. Begg C.B., Cramer L.D., Hoskins W.J., Brenan M.F. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998, 280:1747-1751.
34. Glasgow R.E., Showsrack J.A., Katz P.P., Corvera C.U., Warren R.S. The relationship betwen hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arc Surg 1999, 134:30-35.
35. Choti M.A., Bowman H.M., Pitt H.A., Sosa Sitzamna J.A., Cameron J.C., et al. Should hepatic resections be performed at high volume referral centers?. Gastrointestinal Surg 1998, 2:11-20.
36. Figueras J., Valls C., Fabregat J., Serrano T., Jaurrieta E. Equipamiento, experiencia mínima y estándares en la cirugía hepatobiliopancreática (HPB. Cir Esp 2002, 71:201-206.
37. Jaeck D., Bachellier P., Weber J.C., Boudjema K., Vaillant J.C. Stratégie chirurgicale dans le traitement de métastases hépatique synchrones des cancers colorectaux. Analyse de 59 malades opérés. Chirurgie 1999, 124:258-263.
38. Shimamura T., Nakajima Y., Une Y., Namieno T., Ogasawara K., Yamashita K., et al. Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery 1997, 121:135-141.
39. Giacheti S., Itzhaki M., Gruia G. Long term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5.fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999, 10:663-669.
40. Adam R., Avisar E., Ariche A., Giacheti S., Azoulay D., Castaign D., et al. Five years following hepatic resection after neoadyuvant therapy for non resectable colorectal metastase. Ann Surg Oncol 2002, 8:347-353.